Lung Cancer Management in North Carolina: Updates for 2020 - SPOC

Shetal Patel, MD, PhD, from the UNC Lineberger Thoracic Oncology group will describe relevant updates in systemic therapy for lung cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.

Learning Objectives

  • Recognize biomarkers for targeted therapy selection for patients with non-small cell lung cancer
  • Compare immune checkpoint inhibitor treatment options for metastatic non-small cell lung cancer
  • Describe the role of immune checkpoint inhibitors in small cell lung cancer
Course summary
Available credit: 
  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Course opens: 
11/11/2020
Course expires: 
12/31/2027
Rating: 
0
Photo of Shetal A. Patel, MD, PhD 

Shetal A. Patel, MD, PhD

Assistant Professor
Clinical Research
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

Shetal A. Patel, MD, PhD, receives research support from AstraZeneca and has no other relevant financial relationships with commercial interests as defined by the ACCME.

 

This Non-Credit Course does NOT have accreditation for continuing education credits.

The course offers only general participation certificates.

Available Credit

  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Please login or register to take this course.